In this manuscript, we describe a novel synthetic Fer/FerT inhibitor, which compromises mitochondrial integrity, and activates PARP-1 and autophagy, thereby targeting the energy management system of cancer cells, and selectively leading to their necrotic death. This evidence concerns the gene FER and cancer.